Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program

Subjects

Subjects :

Mental Health
Endocrinology
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Endocrinology, Diabetes and Metabolism
Internal Medicine
Humans
Canagliflozin
Sodium-Glucose Transporter 2 Inhibitors

Details

ISSN :

14631326 and 14628902

Volume :

24

Database :

OpenAIRE

Journal :

Diabetes, Obesity and Metabolism

Accession number :

edsair.doi.dedup.....f85f9ddae1a8e1200532da66d557fea5

Full Text :

https://doi.org/10.1111/dom.14832